Table 8.
Bleeding complications of percutaneous native kidney biopsies in pediatric nephrology facilities for child and adolescent patients
| Year | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|
| Number of facilities | 35 | 32 | 37 | 104 |
| Number of biopsies | 642 | 499 | 544 | 1685 |
| Macroscopic hematuria with no treatment (%) | 28 (4.4) | 42 (8.4) | 35 (6.4) | 105 (6.2) |
| Bleeding complications with treatment (%) | 2 (0.3) | 4 (0.8) | 5 (0.9) | 11 (0.7) |
| Erythrocyte transfusiona (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Surgical hemostasisa (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Transcatheter arterial embolizationa (%) | 0 (0) | 0 (0) | 1 (0.2) | 1 (0.06) |
| Bladder lavagea (%) | 2 (0.3) | 2 (0.4) | 5 (0.9) | 9 (0.5) |
| Nephrectomya (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Death from severe bleedinga (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
aMultiple selections allowed in the same biopsy